The ownership problem
Picture the RA/QA operations lead in a process redesign meeting before PMS ownership is assigned. Complaints, service records, recalls, alerts, and public signals live with different owners, so the team cannot see the full evidence path.
The first move is not to declare whether the signal raises safety, compliance, reportability, equivalence, or exposure questions. The useful move is to connect evidence streams, name missing records, and prepare the owner-specific review questions.
Internal-external PMS workflow map
| Evidence stream | Owner question |
|---|---|
| Complaint and service records | Who confirms trend, recurrence, user context, and product-family relevance? |
| CAPA and risk records | Which file receives the review note or escalation trigger? |
| Supplier and component signals | Who checks supplier evidence, validation records, and component similarity? |
| Public recalls and alerts | Which source was checked and what can it not decide? |
| Management review | Which unresolved questions need leadership visibility? |
What the operating rhythm should produce
- A source ledger for external public signals.
- An internal evidence register with record owner and status.
- A crosswalk between signal type, product family, owner, and next review trigger.
- A decision boundary that keeps public clues separate from qualified conclusions.
Source ledger
What it can tell you
United States public recall and early-alert records that can trigger external monitoring questions.
What it cannot decide
How a specific company's complaint, CAPA, risk, supplier, or management-review process should resolve the signal.
What it can tell you
Canadian public recall and safety-alert records that can support external signal monitoring.
What it cannot decide
Importer, distributor, complaint-handling, reportability, or field-action decisions for a specific company.
What it can tell you
European medical-device sector context and public resources that may frame EU-facing external signal checks.
What it cannot decide
Whether one manufacturer's PMS, PMCF, vigilance, clinical, or conformity evidence is sufficient.
Frequently asked questions
Should internal and external PMS live in separate systems?
They can originate in separate systems, but the review workflow should connect them through source labels, owner assignments, and escalation triggers.
What is the first useful output?
An internal-external PMS workflow map with evidence streams, owners, source links, open questions, and review triggers.
Need one PMS workflow map instead of scattered owners?
Send the product family, current evidence streams, and ownership question. We can scope an internal-external PMS map for qualified review.
Reader feedback
Useful pages should feed the next topic choices. Leave a signal or a short comment.